DICER1 and neoplasm: In a recent longitudinal study by Stewart et al., 207 carriers of DICER1 pathogenic variants were tracked for their risk of developing any neoplasia up to a certain age: Only 5.3% of the patients developed a tumor before the age of 10 years and of 31.5% before the age of 60 [12].